Abstract | BACKGROUND: METHODS:
Tumor biopsies from normal lung tissue and from a large cohort (n = 169) of NSCLC patients were examined for GAGE, NY-ESO-1 and SP17 protein expression by immunohistochemical analysis. The expression of these antigens was further matched to clinical and pathological features using univariate cox regression analysis. RESULTS: GAGE and NY-ESO-1 cancer/testis antigens were not expressed in normal lung tissue, while SP17 was expressed in ciliated lung epithelia. The frequency of GAGE, NY-ESO-1 and SP17 expression in NSCLC tumors were 26.0% (44/169), 11.8% (20/169) and 4.7% (8/169), respectively, and 33.1% (56/169) of the tumors expressed at least one of these antigens. In general, the expression of GAGE, NY-ESO-1 and SP17 was not significantly associated with a specific histotype ( adenocarcinoma vs. squamous cell carcinoma), but high-level GAGE expression (>50%) was more frequent in squamous cell carcinoma (p = 0.02). Furthermore, the frequency of GAGE expression was demonstrated to be significantly higher in stage II-IIIa than stage I NSCLC (17.0% vs. 35.8%; p = 0.02). Analysis of the relation between tumor expression of GAGE and NY-ESO-1 and survival endpoints revealed no significant associations. CONCLUSION:
|
Authors | Morten F Gjerstorff, Mette Pøhl, Karen E Olsen, Henrik J Ditzel |
Journal | BMC cancer
(BMC Cancer)
Vol. 13
Pg. 466
(Oct 08 2013)
ISSN: 1471-2407 [Electronic] England |
PMID | 24103781
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Antigens, Surface
- CTAG1B protein, human
- Calmodulin-Binding Proteins
- Carrier Proteins
- Membrane Proteins
- SPA17 protein, human
|
Topics |
- Antigens, Neoplasm
(genetics, metabolism)
- Antigens, Surface
(genetics, metabolism)
- Calmodulin-Binding Proteins
- Carcinoma, Non-Small-Cell Lung
(genetics, metabolism, mortality, pathology)
- Carrier Proteins
(genetics, metabolism)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Lung Neoplasms
(genetics, metabolism, mortality, pathology)
- Male
- Membrane Proteins
(genetics, metabolism)
- Neoplasm Staging
- Prognosis
- Testis
(metabolism)
|